Axitinib API Market to Reach USD 10.1 Billion by 2032 Driven by Rising Cancer Therapies
According to WiseGuy Reports, the Axitinib API Market was valued at USD 4.85 billion in 2023 and reached USD 5.26 billion in 2024. The market is projected to grow to USD 10.1 billion by 2032, registering a CAGR of 8.49% during the forecast period. Market expansion is being driven by increasing cancer incidences, growing adoption of targeted therapies, rising demand for personalized medicine,...
0 Comments 0 Shares 30 Views 0 Reviews